Search Results - "Birmingham, Mary C."

Linezolid for the Treatment of Multidrug-Resistant, Gram-Positive Infections: Experience from a Compassionate-Use Program by Birmingham, Mary C., Rayner, Craig R., Meagher, Alison K., Flavin, Susan M., Batts, Donald H., Schentag, Jerome J.

“…Linezolid was provided for treatment of multidrug-resistant, gram-positive infections through a compassionate-use program. Patients (n = 796) received 600 mg…”
Get full text

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial by Spertus, John A., Birmingham, Mary C., Nassif, Michael, Damaraju, C. V., Abbate, Antonio, Butler, Javed, Lanfear, David E., Lingvay, Ildiko, Kosiborod, Mikhail N., Januzzi, James L.

“…Large traditional clinical trials suggest that sodium-glucose co-transporter 2 inhibitors improve symptoms in patients with heart failure and reduced ejection…”
Get full text

Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program by MEAGHER, Alison K, FORREST, Alan, RAYNER, Craig R, BIRMINGHAM, Mary C, SCHENTAG, Jerome J

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Clinical Experience with Linezolid for the Treatment of Nocardia Infection by Moylett, Edina H., Pacheco, Susan E., Brown-Elliott, Barbara A., Perry, Tracy R., Buescher, E. Stephen, Birmingham, Mary C., Schentag, Jerome J., Gimbel, Joseph F., Apodaca, Aaron, Schwartz, Margot A., Rakita, Robert M., Wallace, Richard J.

“…Linezolid is an oxazolidinone that has activity against most gram-positive bacteria, including in vitro activity against all Nocardia species and strains. We…”
Get full text

Association of Recent Use of Non–Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase by Kam, Wayneho, Holmes, DaJuanicia N, Hernandez, Adrian F, Saver, Jeffrey L, Fonarow, Gregg C, Smith, Eric E, Bhatt, Deepak L, Schwamm, Lee H, Reeves, Mathew J, Matsouaka, Roland A, Khan, Yosef M, Unverdorben, Martin, Birmingham, Mary C, Lyden, Patrick D, Asimos, Andrew W, Altschul, Dorothea, Schoonover, Timothy L, Jumaa, Mouhammad A, Nomura, Jason T, Suri, Muhammad Fareed K, Moore, S. Arthur, Lafranchise, Eugene F, Olson, DaiWai, Peterson, Eric D, Xian, Ying

“…IMPORTANCE: Current guidelines recommend against use of intravenous alteplase in patients with acute ischemic stroke who are taking non–vitamin K antagonist…”
Get full text

Recruitment Strategies of a Decentralized Randomized Placebo Controlled Clinical Trial: The Canagliflozin Impact on Health Status, Quality of Life and Functional Status in Heart Failure (CHIEF-HF) Trial by Nassif, MICHAEL, BIRMINGHAM, MARY C., LANFEAR, DAVID E., GOLBUS, JESSICA R., GUPTA, BHANU, FAWCETT, CHRISTINA, HARRISON, MARIA C., SPERTUS, JOHN A.

“…[Display omitted] There has been growing Interest in patient-centered clinical trials using mobile technologies to reduce the need for in-person visits. The…”
Get full text

Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial by Turakhia, Mintu, Sundaram, Vandana, Smith, Shea N., Ding, Victoria, Michael Ho, P., Kowey, Peter R., Piccini, Jonathan P., Foody, JoAnne, Birmingham, Mary C., Ianus, Juliana, Rajmane, Amol, Mahaffey, Kenneth W.

“…Improving adherence to direct oral anticoagulants (DOAC) is challenging, and simple text messaging reminders have not been effective. SmartADHERE was a…”
Get full text

Pharmacodynamics of Vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections by MOISE-BRODER, Pamela A, FORREST, Alan, BIRMINGHAM, Mary C, SCHENTAG, Jerome J

“…Vancomycin is commonly used to treat staphylococcal infections, but there has not been a definitive analysis of the pharmacokinetics of this antibacterial in…”
Get full text

Novel Trial Design: CHIEF-HF by Spertus, John A., Birmingham, Mary C., Butler, Javed, Lingvay, Ildiko, Lanfear, David E., Abbate, Antonio, Kosiborod, Mikhail L., Fawcett, Christina, Burton, Paul, Damaraju, C.V., Januzzi, James L., Whang, John

“…The expense of clinical trials mandates new strategies to efficiently generate evidence and test novel therapies. In this context, we designed a decentralized,…”
Get full text

Association Between Wearable Device Measured Activity and Patient-Reported Outcomes for Heart Failure by Golbus, Jessica R, Gosch, Kensey, Birmingham, Mary C, Butler, Javed, Lingvay, Ildiko, Lanfear, David E, Abbate, Antonio, Kosiborod, Mikhail L, Damaraju, C V, Januzzi, Jr, James L, Spertus, John, Nallamothu, Brahmajee K

“…Wearable devices are increasingly used in research and clinical care though the relevance of their data in the context of validated outcomes remains unknown…”
Get full text

Clinical pharmacodynamics of linezolid in seriously ill Patients treated in a compassionate use programme by RAYNER, Craig R, FORREST, Alan, MEAGHER, Alison K, BIRMINGHAM, Mary C, SCHENTAG, Jerome J

“…To characterise the pharmacokinetic-pharmacodynamic relationships for linezolid efficacy. Retrospective nonblinded analysis of severely debilitated adult…”
Get full text

Screening for Postpartum Depression in a Pediatric Emergency Department by Birmingham, Mary C, Chou, Katherine J, Crain, Ellen F

“…OBJECTIVE:The objective was to determine whether a 3-question version of the Edinburgh Postpartum Depression Scale (EPDS) performs as well as the full EPDS in…”
Get full text

E5 Murine Monoclonal Antiendotoxin Antibody in Gram-Negative Sepsis: A Randomized Controlled Trial by Angus, Derek C, Birmingham, Mary C, Balk, Robert A, Scannon, Patrick J, Collins, David, Kruse, James A, Graham, Donald R, Dedhia, Harakh V, Homann, Scott, MacIntyre, Neil, for the E5 Study Investigators

“…CONTEXT Knowledge and understanding of gram-negative sepsis have grown over the past 20 years, but the ability to treat severe sepsis successfully has not…”
Get full text

The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin by Moise, Pamela A., Forrest, Alan, Birmingham, Mary C., Schentag, Jerome J.

“…Objective: The incidence of infections caused by methicillin-resistant Staphylococcus aureus continues to increase annually. Unfortunately, only a few…”
Get full text

Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus by Moise, PA, Forrest, A, Bhavnani, SM, Birmingham, MC, Schentag, JJ

“…Treatment factors predictive of clinical and microbiological outcomes and the relationship between a pneumonia scoring system and clinical outcomes in…”
Get full text

Genesis of Methicillin-Resistant Staphylococcus aureus (MRSA), How Treatment of MRSA Infections Has Selected for Vancomycin-Resistant Enterococcus faecium, and the Importance of Antibiotic Management and Infection Control by Schentag, Jerome J., Hyatt, Judith M., Carr, James R., Paladino, Joseph A., Birmingham, Mary C., Zimmer, Gabrial S., Cumbo, Thomas J.

“…We extensively studied the epidemiology and time course of endemic methicillin-resistant Staphylococcus aureus (MRSA) in the Millard Fillmore Hospital, a…”
Get full text

Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose by Birmingham, M C, Guarino, R, Heller, A, Wilton, J H, Shah, A, Hejmanowski, L, Nix, D E, Schentag, J J

“…Intravenous ciprofloxacin is frequently prescribed for the treatment of infections due to nosocomially acquired gram-negative organisms, including those…”
Get full text

CRITICAL CARE PATIENTS WITH SIGNIFICANT, RESISTANT, GRAM-POSTIVE INFECTIONS ENROLLED IN THE LINEZOLID COMPASSIONATE USE PROTOCOL by Birmingham, Mary C, Craig, Rayner R, Hafkin, Barry, Todd, Wesley Mark, Flavin, Susan M, Root, Jennifer D, Zimmer, Gabrial S, Batts, Donald H, Schentag, Jerome J

Get full text

Clinical experience with linezolid for the treatment of Nocardia infection by MOYLEN, Edina H, PACHECO, Susan E, RAKITA, Robert M, WALLACE, Richard J, BROWN-ELLION, Barbara A, PERRY, Tracy R, BUESCHER, E. Stephen, BIRMINGHAM, Mary C, SCHENTAG, Jerome J, GIMBEL, Joseph F, APODACA, Aaron, SCHWARTZ, Margot A

Get full text

COST-EFFECTIVENESS ANALYSIS OF NEUROMUSCULAR BLOCKING AGENTS (NMBAs) USED IN THE INTENSIVE CARE UNITS by Root, Jennifer D., Collins, David A., Birmingham, Mary C., Schentag, Jerome J.

Get full text